Advertisement
Novartis AG

Novartis AG (NVS) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

NVSNYSE
HealthcareDrug Manufacturers - General
$153.07
$0.85(0.55%)
U.S. Market opens in 64h 23m
Advertisement

Novartis AG (NVS)

Meyka AI Score

Z

Key Financials

Market Cap292B
P/E Ratio20.89
EPS (TTM)$6.98
ROE0.32%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

NVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.89 and a market capitalization of 292B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.58%
5-Day Change
3.64%
1-Month Change
3.28%
3-Month Change
-0.80%
6-Month Change
15.43%
Year-to-Date (YTD) Change
10.99%
1-Year Change
26.70%
3-Year Change
61.70%
5-Year Change
72.79%
All-Time (Max) Change
872.79%

Contact Information

41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

758,830 Employees
IPO DateNov 7, 1996
CountryCH
Actively Trading

Frequently Asked Questions